Catalyst Wire Dossier Catalyst Wire Dossier

TIVICAY PD

dolutegravir sodium · ViiV Healthcare Company
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for TIVICAY PD, covering 2020-06-12 to 2026-08-25. Get the full timeline:

Most recent: FDA Approved: TIVICAY PD — Supplemental Application (ViiV Healthcare Company)

See pricing